Clinical trial
Study to Assess the Efficacy and Safety of Dysport® in Upper Back Myofascial…
NCT00134810 · Ipsen, Industry · Completed
Key facts
| NCT number | NCT00134810 |
|---|---|
| Title | Study to Assess the Efficacy and Safety of Dysport® in Upper Back Myofascial Pain Syndrome |
| Official title | A Phase II Multicentre Multinational Prospective Randomised Double-blind Placebo-controlled Study Assessing the Efficacy and Safety of a Single Application of Three Doses of Dysport® in Patients With Upper Back Myofascial Pain Syndrome |
| Lead sponsor | Ipsen, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Myofascial Pain Syndromes |
| Intervention type | Biological |
| Interventions | Botulinum toxin type A |
| Enrollment | 381 |
| Start date | Mar 1, 2005 |
| Primary completion | May 18, 2006 |
| Completion | May 18, 2006 |
| First posted | Aug 25, 2005 |
| Last update posted | Nov 22, 2019 |
| Countries | Czechia, Germany, Italy, Poland, Portugal, Spain |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: